[Primary malignant nephrosclerosis (author's transl)]. 1975

U Frotscher, and M Thelen, and H J Fuchs, and G Jenett, and U Klehr, and G Richter, and R Wilbrandt

Primary malignant nephrosclerosis shows a haemolytic-uraemic symptomatology and can be differentiated from secondary malignant nephrosclerosis on clinical and histological grounds. The disease was observed in 4 patients: a 25-year-old man and 3 women aged 19, 28 and 49 years. The disease is characterized by a fulminating course, malignant hypertension with progressive retinopathy, and development of progressive renal failure with subsequent irreversible anuria. In addition haemolytic anaemia or posthaemolytic states as well as consumption coagulopathy occur. In 2 cases schizozytes and in particular helmet-shaped forms could be demonstrated. On histology an obliterating necrotizing vascular change is seen which is limited to the kidneys as was demonstrated in one case by angiography. Therapeutic attempts included antibiotics, steroids, heparin, streptokinase, antihypertensive drugs, and haemodialysis. The 3 female patients died, the man survived after bilateral nephrectomy.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D009400 Nephrosclerosis Hardening of the KIDNEY due to infiltration by fibrous connective tissue (FIBROSIS), usually caused by renovascular diseases or chronic HYPERTENSION. Nephrosclerosis leads to renal ISCHEMIA. Nephroscleroses
D012164 Retinal Diseases Diseases involving the RETINA. Disease, Retinal,Diseases, Retinal,Retinal Disease
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses

Related Publications

U Frotscher, and M Thelen, and H J Fuchs, and G Jenett, and U Klehr, and G Richter, and R Wilbrandt
September 1973, Klinische Wochenschrift,
U Frotscher, and M Thelen, and H J Fuchs, and G Jenett, and U Klehr, and G Richter, and R Wilbrandt
December 1977, Deutsche medizinische Wochenschrift (1946),
U Frotscher, and M Thelen, and H J Fuchs, and G Jenett, and U Klehr, and G Richter, and R Wilbrandt
December 1976, Clinical science and molecular medicine. Supplement,
U Frotscher, and M Thelen, and H J Fuchs, and G Jenett, and U Klehr, and G Richter, and R Wilbrandt
January 1980, Lijecnicki vjesnik,
U Frotscher, and M Thelen, and H J Fuchs, and G Jenett, and U Klehr, and G Richter, and R Wilbrandt
January 1977, Current topics in pathology. Ergebnisse der Pathologie,
U Frotscher, and M Thelen, and H J Fuchs, and G Jenett, and U Klehr, and G Richter, and R Wilbrandt
August 1976, Deutsche medizinische Wochenschrift (1946),
U Frotscher, and M Thelen, and H J Fuchs, and G Jenett, and U Klehr, and G Richter, and R Wilbrandt
January 1977, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
U Frotscher, and M Thelen, and H J Fuchs, and G Jenett, and U Klehr, and G Richter, and R Wilbrandt
January 1974, Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology,
U Frotscher, and M Thelen, and H J Fuchs, and G Jenett, and U Klehr, and G Richter, and R Wilbrandt
January 1978, Bulletin du cancer,
U Frotscher, and M Thelen, and H J Fuchs, and G Jenett, and U Klehr, and G Richter, and R Wilbrandt
January 1979, Zeitschrift fur Erkrankungen der Atmungsorgane,
Copied contents to your clipboard!